Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Acrivon Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −1 vs. Q3 2023
- Shares held
- 15.3M
- +215.2K (+1.4%) vs. Q3 2023
- Total value
- $74.5M
- −$69.8M (−48.4%) vs. Q3 2023
- New holders
- 3
- 16 more added
- Sold out
- 4
- 9 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 260 | $1.28K | 0.00% | +122+88.4% | Added |
| STRS Ohio | 800 | $3.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 695 | $3.42K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 806 | $3.97K | 0.00% | +518+179.9% | Added |
| Legal & General Group Plc | 839 | $4.13K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,231 | $6.00K | 0.00% | −113−8.4% | Reduced |
| California State Teachers Retirement System | 1,431 | $7.04K | 0.00% | −487−25.4% | Reduced |
| Tower Research Capital LLC (TRC) | 2,018 | $9.93K | 0.00% | +763+60.8% | Added |
| Citigroup Inc | 2,047 | $10.1K | 0.00% | +1,817+790.0% | Added |
| New York State Common Retirement Fund | 2,273 | $11.2K | 0.00% | −24−1.0% | Reduced |
| Royal Bank of Canada | 2,488 | $12.0K | 0.00% | +927+59.4% | Added |
| Wells Fargo & Company | 2,691 | $13.2K | 0.00% | +530+24.5% | Added |
| American International Group, Inc. | 4,321 | $21.3K | 0.00% | −17−0.4% | Reduced |
| Rhumbline Advisers | 9,270 | $45.6K | 0.00% | −207−2.2% | Reduced |
| Bank of America Corp | 10,088 | $49.6K | 0.00% | +756+8.1% | Added |
| AAFCPAs Wealth Management, LLC | 10,678 | $52.5K | 0.03% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 11,821 | $58.2K | 0.00% | 00.0% | Unchanged |
| Marex Group plc | 13,187 | $64.9K | 0.00% | +13,187 | New |
| Exchange Traded Concepts, LLC | 13,289 | $65.4K | 0.00% | +3,370+34.0% | Added |
| Barclays PLC | 24,484 | $120.5K | 0.00% | +10,384+73.6% | Added |
| Bank of New York Mellon Corp | 24,795 | $122.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 25,631 | $126.1K | 0.00% | +20,688+418.5% | Added |
| D. E. Shaw & Co., Inc. | 31,939 | $157.1K | 0.00% | −14,811−31.7% | Reduced |
| Bridgeway Capital Management, LLC | 31,981 | $157.3K | 0.00% | +31,981 | New |
| JPMorgan Chase & Co | 33,343 | $164.0K | 0.00% | +6,771+25.5% | Added |
| Jacobs Levy Equity Management, Inc | 46,072 | $226.7K | 0.00% | +46,072 | New |
| Charles Schwab Investment Management Inc | 68,501 | $337.0K | 0.00% | +840+1.2% | Added |
| Northern Trust Corp | 80,149 | $394.3K | 0.00% | +7,427+10.2% | Added |
| UBS Oconnor LLC | 93,443 | $459.7K | 0.01% | −11,557−11.0% | Reduced |
| DAFNA Capital Management LLC | 131,351 | $646.2K | 0.15% | +54,499+70.9% | Added |
| State Street Corp | 133,276 | $655.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 189,200 | $931.0K | 0.00% | −359−0.2% | Reduced |
| Federated Hermes, Inc. | 226,375 | $1.11M | 0.00% | 00.0% | Unchanged |
| NEA Management Company, LLC | 430,252 | $1.29M | 0.09% | 00.0% | Unchanged |
| Vanguard Group Inc | 475,977 | $2.34M | 0.00% | +7,570+1.6% | Added |
| BlackRock Inc. | 565,832 | $2.78M | 0.00% | +37,072+7.0% | Added |
| Marshall Wace, LLP | 597,469 | $2.94M | 0.01% | 00.0% | Unchanged |
| Wellington Management Group LLP | 888,130 | $4.37M | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,649,659 | $8.12M | 0.01% | −7980.0% | Reduced |
| Sands Capital Ventures, LLC | 1,652,605 | $8.13M | 2.26% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $14.8M | 0.33% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,810,508 | $23.7M | 0.37% | 00.0% | Unchanged |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,564−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |